InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30
United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
George C. Clark
17 Nov 2025
VP, Chief Accounting Officer
Buy indirect
17,000
$8.52
$144.77K
Vlad Coric
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
Vlad Coric
13 Nov 2025
Chief Executive Officer
Buy indirect
333,333
$7.50
$2.50M
John W Childs
13 Nov 2025
Director
Buy indirect
3,333,333
$7.50
$25.00M
Gregory Bailey
13 Nov 2025
Director
Buy
400,000
$7.50
$3.00M
John W Childs
4 Mar 2025
Director
Buy indirect
900
$30.73
$27.65K
John W Childs
4 Mar 2025
Director
Buy indirect
3,400
$30.73
$104.47K
John W Childs
4 Mar 2025
Director
Buy indirect
3,400
$30.73
$104.47K
John W Childs
4 Mar 2025
Director
Buy indirect
25,000
$30.39
$759.65K
John W Childs
30 Dec 2024
Director
Buy indirect
29,000
$35.94
$1.04M
Vlad Coric
2 Oct 2024
Chief Executive Officer
Buy indirect
21,052
$47.50
$999.97K
John W Childs
2 Oct 2024
Director
Buy indirect
21,052
$47.50
$999.97K
Gregory Bailey
24 Sep 2024
Director
Buy
5,000
$44.19
$220.97K
John W Childs
18 Jul 2024
Director
Buy indirect
28,400
$35.67
$1.01M
Bruce Car
17 Jun 2024
Chief Scientific Officer
Buy indirect
30,000
$33.58
$1.01M
John W Childs
30 May 2024
Director
Buy indirect
28,000
$35.58
$996.24K
John W Childs
13 May 2024
Director
Buy indirect
28,500
$35.17
$1.00M
Gregory Bailey
13 May 2024
Director
Buy
15,000
$34.19
$512.88K
Gregory Bailey
24 Apr 2024
Director
Buy
25,503
$39.18
$999.17K
Vlad Coric
22 Apr 2024
Chief Executive Officer
Buy
121,951
$41.00
$5.00M
John W Childs
22 Apr 2024
Director
Buy indirect
73,170
$41.00
$3.00M
John W Childs
22 Apr 2024
Director
Buy indirect
97,560
$41.00
$4.00M
John W Childs
22 Apr 2024
Director
Buy indirect
24,391
$41.00
$1.00M
Gregory Bailey
22 Apr 2024
Director
Buy
48,780
$41.00
$2.00M
Matthew Buten
5 Oct 2023
Chief Financial Officer
Buy
22,727
$22.00
$499.99K
Vlad Coric
5 Oct 2023
Chief Executive Officer
Buy
113,637
$22.00
$2.50M
Vlad Coric
5 Oct 2023
Chief Executive Officer
Buy indirect
340,908
$22.00
$7.50M
John W Childs
5 Oct 2023
Director
Buy indirect
136,545
$22.00
$3.00M
John W Childs
5 Oct 2023
Director
Buy indirect
318,000
$22.00
$7.00M
Gregory Bailey
4 Oct 2023
Director
Buy
17,817
$22.57
$402.09K
John W Childs
30 Aug 2023
Director
Buy indirect
50,000
$18.44
$922.18K
John W Childs
4 Aug 2023
Director
Buy indirect
100,000
$19.78
$1.98M
Vlad Coric
31 Oct 2022
Chief Executive Officer
Buy
25,800
$15.97
$412.00K
Vlad Coric
28 Oct 2022
Chief Executive Officer
Buy indirect
100,000
$14.82
$1.48M
Vlad Coric
28 Oct 2022
Chief Executive Officer
Buy
41,930
$14.87
$623.35K
Julia P Gregory
25 Oct 2022
Director
Buy
9,523
$10.50
$99.99K
Matthew Buten
25 Oct 2022
Chief Financial Officer
Buy
142,857
$10.50
$1.50M
John W Childs
25 Oct 2022
Director
Buy
3,900,000
$10.50
$40.95M
Vlad Coric
25 Oct 2022
Chief Executive Officer
Buy
853,380
$10.50
$8.96M
Gregory Bailey
25 Oct 2022
Director
Buy
200,000
$10.50
$2.10M
John W Childs
5 Oct 2022
Director
Buy
32,841
$9.70
$318.40K
John W Childs
5 Oct 2022
Director
Buy
241,300
$8.88
$2.14M
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
2,100
$12.35
$25.93K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
52,523
$11.79
$619.16K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
80,606
$10.82
$871.91K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
34,459
$9.89
$340.97K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
73,005
$8.82
$644.13K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
54,329
$11.83
$642.61K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
80,907
$10.83
$875.84K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
34,515
$9.90
$341.84K
Vlad Coric
5 Oct 2022
Chief Executive Officer
Buy indirect
73,331
$8.82
$647.03K
Show all 100 transactions →

What was left out

Form 4 filings counted 107
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 76,404,592
History held since 5 Oct 2022